Excelsior Medical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 11, 2022 at 04:49 pm EDT
Share
Excelsior Medical Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 1,674.29 million compared to TWD 1,580.43 million a year ago. Net income was TWD 140.18 million compared to TWD 136.42 million a year ago. Basic earnings per share from continuing operations was TWD 0.9429 compared to TWD 0.9238 a year ago. Diluted earnings per share from continuing operations was TWD 0.9429 compared to TWD 0.9143 a year ago.
For the six months, sales was TWD 3,382.62 million compared to TWD 3,209.76 million a year ago. Net income was TWD 308.12 million compared to TWD 267.1 million a year ago. Basic earnings per share from continuing operations was TWD 2.0762 compared to TWD 1.8 a year ago. Diluted earnings per share from continuing operations was TWD 2.0667 compared to TWD 1.8 a year ago.
EXCELSIOR MEDICAL CO., LTD. is a Taiwan-based company principally engaged in the distribution, maintenance and leasing of medical equipment and supplies. The Companyâs principal products include artificial kidneys, hemodialysis blood tubing sets and epidural needles, dialysis liquid medicines and powder medicines, dialysis machines, human erythropoietin, surgery consumable materials, blood bags, plasma replacement machines and beauty medical equipment, among others. The Company is also involved in the production and sales of self-owned soybean milk machines, as well as household air fresheners under the brand name of Coway. The Company mainly operates its businesses in domestic market and overseas markets.
EXCELSIOR MEDICAL CO., LTD. 
